Medical Condition News

RSS

New method can reduce environmental impact caused by manufacturing processes

The human and environmental dangers posed by a widely used manufacturing technique could be almost eradicated thanks to research led by Plymouth University.

9 Oct 2014

New Colombia creates joint venture to produce cannabis and hemp based medicinal products

New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce they have formed a joint venture to produce cannabis and hemp based medicinal products in Colombia in association with an indigenous community in Colombia.

9 Oct 2014

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.

9 Oct 2014

VAL-083 drug compound shows promise against non-small cell lung cancer

DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.

9 Oct 2014

HemoShear completes first-phase development of novel cancer drug discovery platform

HemoShear today announced that it has completed the first phase of development of a novel cancer drug discovery platform that replicates human tumor biology and responds to clinically-relevant drug concentrations.

9 Oct 2014

Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

Isis Pharmaceuticals, Inc. announced today that it has earned an $18 million milestone payment from GlaxoSmithKline related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).

9 Oct 2014

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve.

9 Oct 2014

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.

9 Oct 2014

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Heart attack survivors often experience dangerous heart rhythm disturbances during treatment designed to restore blood flow to the injured heart muscle, a common and confounding complication of an otherwise lifesaving intervention.

9 Oct 2014

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

9 Oct 2014

University of Luxembourg researchers identify potential new ways to test colorectal cancer

Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.

9 Oct 2014

Academy of Nutrition and Dietetics applauds USPSTF's recommendations on screening for diabetes

The Academy of Nutrition and Dietetics applauds the work of the United States Preventative Services Task Force for amending its recommendations on screening for diabetes based on its review of current best evidence.

9 Oct 2014

Women with healthy diet and lifestyle less likely to have stroke

Women with a healthy diet and lifestyle may be less likely to have a stroke by more than half, according to a study published in the October 8, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Oct 2014

Temple researchers to create awareness about healthy diet among low-income Asian Americans

Although low-income Asian Americans are at a high risk for diabetes, hypertension, heart attack and stroke, they are under a misconception that their diet is healthy and not a risk factor for these chronic diseases.

9 Oct 2014

Bad sleep quality may trigger insomnia in older adults

Reports of insomnia are common among the elderly, but a new study finds that sleep problems may stem from the quality of rest and other health concerns more than the overall amount of sleep that patients get.

9 Oct 2014

Discovery could lead to treatments for alcohol-related liver diseases

Researchers at the University of Missouri School of Medicine have identified epigenetic protein changes caused by binge drinking, a discovery that could lead to treatments for alcohol-related liver diseases.

9 Oct 2014

BRCA mutations carry risks for salivary gland cancer, breast cancer

The risk of developing cancer in a salivary gland might be higher in people with mutations in either of two genes associated with breast and ovarian cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

9 Oct 2014

UCI to receive $8 million from NIH to study brain cell activity in motor neuron disorders

UC Irvine will receive $8 million from the National Institutes of Health to establish one of six national centers dedicated to creating a database of human cellular responses that will accelerate efforts to develop new therapies for many diseases.

9 Oct 2014

AT2101 drug, evaluated for Gaucher disease, slows progression of Parkinson's disease in mice

A new study from UCLA found that a drug being evaluated to treat an entirely different disorder helped slow the progression of Parkinson's disease in mice.

9 Oct 2014

Increased risk of premature death associated with higher BMI similar for African Americans, whites

A study from American Cancer Society researchers finds the increased risk of premature death associated with a higher body mass index (BMI) is similar for African Americans and whites, in contrast to previous, smaller studies that indicated the association may be weaker for African Americans.

9 Oct 2014

Medical Condition News

New method can reduce environmental impact caused by manufacturing processes

New Colombia creates joint venture to produce cannabis and hemp based medicinal products

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

VAL-083 drug compound shows promise against non-small cell lung cancer

HemoShear completes first-phase development of novel cancer drug discovery platform

Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

University of Luxembourg researchers identify potential new ways to test colorectal cancer

Academy of Nutrition and Dietetics applauds USPSTF's recommendations on screening for diabetes

Women with healthy diet and lifestyle less likely to have stroke

Temple researchers to create awareness about healthy diet among low-income Asian Americans

Bad sleep quality may trigger insomnia in older adults

Discovery could lead to treatments for alcohol-related liver diseases

BRCA mutations carry risks for salivary gland cancer, breast cancer

UCI to receive $8 million from NIH to study brain cell activity in motor neuron disorders

AT2101 drug, evaluated for Gaucher disease, slows progression of Parkinson's disease in mice

Increased risk of premature death associated with higher BMI similar for African Americans, whites

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News